Immunovia Publishes Interim Report for January-September 2023

LUND, Sweden, Nov. 9, 2023 /PRNewswire/ — July-September 2023 Net sales amounted to KSEK 488 (358) divided by sales of tests KSEK 70 (111) and royalties KSEK 418 (247). Net earnings were MSEK -38.6 (-22.9) and earnings per share before and after dilution were SEK -0.91 (1.01). Cash Flow…